Literature DB >> 21219067

Elevated trajectories of externalizing problems are associated with lower awakening cortisol levels in midadolescence.

John D Haltigan1, Glenn I Roisman, Elizabeth J Susman, Kortnee Barnett-Walker, Kathryn C Monahan.   

Abstract

A growing body of research suggesting a negative association between basal levels of cortisol and persistent antisocial behavior has emerged. The present study examined relations between awakening cortisol levels and antisocial trajectories from ages 5 to 15 years among individuals in the National Institute of Child Health and Human Development Study of Early Child Care and Youth Development. Antisocial behavior was defined by semiparametric group modeling techniques, which revealed antisocial patterns parallel to Moffitt's (1993) taxonomy of antisocial trajectories. In contrast to the claim that biological diatheses are uniquely characteristic of individuals who demonstrate an early-onset pattern of antisocial behavior, our results suggest that individuals with elevated patterns of antisocial behavior between 5 and 15 years of age-irrespective of the timing of onset or desistance-are more likely to evidence lower awakening cortisol levels compared with individuals with persistently low levels of antisocial behavior. PsycINFO Database Record (c) 2011 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219067     DOI: 10.1037/a0021911

Source DB:  PubMed          Journal:  Dev Psychol        ISSN: 0012-1649


  8 in total

1.  Age-of-onset or behavioral sub-types? A prospective comparison of two approaches to characterizing the heterogeneity within antisocial behavior.

Authors:  S Alexandra Burt; M Brent Donnellan; William G Iacono; Matt McGue
Journal:  J Abnorm Child Psychol       Date:  2011-07

2.  An experimental test of the fetal programming hypothesis: Can we reduce child ontogenetic vulnerability to psychopathology by decreasing maternal depression?

Authors:  Elysia Poggi Davis; Benjamin L Hankin; Danielle A Swales; M Camille Hoffman
Journal:  Dev Psychopathol       Date:  2018-08

3.  Circulating FGF21 vs. Stress Markers in Girls during Childhood and Adolescence, and in Their Caregivers: Intriguing Inter-Relations between Overweight/Obesity, Emotions, Behavior, and the Cared-Caregiver Relationship.

Authors:  Eirini V Christaki; Panagiota Pervanidou; Ioannis Papassotiriou; Aimilia Mantzou; Giorgos Giannakakis; Dario Boschiero; George P Chrousos
Journal:  Children (Basel)       Date:  2022-06-02

4.  Longitudinal mediators of a randomized prevention program effect on cortisol for youth from parentally bereaved families.

Authors:  Linda J Luecken; Melissa J Hagan; Irwin N Sandler; Jenn-Yun Tein; Tim S Ayers; Sharlene A Wolchik
Journal:  Prev Sci       Date:  2014-04

5.  Dysregulation of the cortisol diurnal rhythm following prenatal alcohol exposure and early life adversity.

Authors:  Kaitlyn McLachlan; Carmen Rasmussen; Tim F Oberlander; Christine Loock; Jacqueline Pei; Gail Andrew; James Reynolds; Joanne Weinberg
Journal:  Alcohol       Date:  2016-04-01       Impact factor: 2.405

Review 6.  Research review: evaluating and reformulating the developmental taxonomic theory of antisocial behaviour.

Authors:  Graeme Fairchild; Stephanie H M van Goozen; Andrew J Calder; Ian M Goodyer
Journal:  J Child Psychol Psychiatry       Date:  2013-07-04       Impact factor: 8.982

7.  Early adolescent outcomes of joint developmental trajectories of problem behavior and IQ in childhood.

Authors:  Eirini Flouri; Efstathios Papachristou; Emily Midouhas; Heather Joshi; George B Ploubidis; Glyn Lewis
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-04-16       Impact factor: 4.785

8.  Reduced cortisol in boys with early-onset conduct disorder and callous-unemotional traits.

Authors:  Georg G von Polier; Beate Herpertz-Dahlmann; Kerstin Konrad; Kristine Wiesler; Jana Rieke; Monika Heinzel-Gutenbrunner; Christian J Bachmann; Timo D Vloet
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.